0 Commentarii
0 Distribuiri
6K Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
(R)-Duloxetine Market Industry Analysis (2026-2034): Expanding Demand for Chiral APIs and Neuropathic Pain Therapies Drives Pharmaceutical GrowthGlobal (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period. (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...0 Commentarii 0 Distribuiri 212 Views 0 previzualizare
-
Global Lactulose Concentrate Syrup Market Growth Outlook (2026-2034): Digestive Health Demand, Pharmaceutical Expansion, and Regional Industry AnalysisGlobal Lactulose Concentrate Syrup market demonstrates steady growth, with its valuation reaching USD 152 million in 2023 and projected to expand at a CAGR of 4.10% through 2032, reaching approximately USD 218.22 million. This growth trajectory stems from rising applications in pharmaceuticals and food industries, particularly in regions witnessing increased healthcare expenditure and digestive...0 Commentarii 0 Distribuiri 246 Views 0 previzualizare
-
"Tablet Coatings Market Trends: How the Industry Will Evolve by 2031"With the rise of personalized medicine, tablet coatings are becoming increasingly important. Tailored tablet coatings that can accommodate specific dosages or delivery mechanisms for individualized treatments are emerging. This trend presents a huge opportunity for companies specializing in custom coatings for unique therapeutic regimens. The Tablet Coatings Market is poised for...0 Commentarii 0 Distribuiri 7K Views 0 previzualizare1
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentarii 0 Distribuiri 978 Views 0 previzualizare
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Competitive Landscape of the Performance Enhancing Drugs MarketGrowing demand for endurance improvement solutions is influencing pharmaceutical development strategies.New drug delivery technologies are enhancing safety and efficacy.Expanding clinical trials are expected to create future growth opportunities. The Performance Enhancing Drugs Market The market is projected to grow at a CAGR of 7.2% from 2025 to 2031, with valuation expected to expand from US$...0 Commentarii 0 Distribuiri 6K Views 0 previzualizare
-
Contract Manufacturing Boom Supporting API CDMO Market ExpansionRegulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion. Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...0 Commentarii 0 Distribuiri 7K Views 0 previzualizare2
-
Cough and Cold Medicine Market Projected to Grow at 4.3% CAGR Through 2034, Driven by OTC DemandAccording to a new report from Intel Market Research, the global cough and cold medicine market was valued at USD 21.5 billion in 2025 and is projected to reach USD 32.1 billion by 2034, growing at a steady CAGR of 4.3% during the forecast period (2026–2034). This growth stems from rising global incidences of respiratory infections, increasing self-medication practices, and continuous...0 Commentarii 0 Distribuiri 3K Views 0 previzualizare
-
Dapoxetine Market Future Trends Shaping Growth and Innovation to 2034The global landscape for dapoxetine is evolving steadily, supported by increasing recognition of men’s health issues and improved access to treatment solutions. Changing patient behavior and growing openness toward addressing sexual wellness concerns are influencing demand patterns across regions. Healthcare providers are also playing a more proactive role in diagnosing and managing...0 Commentarii 0 Distribuiri 807 Views 0 previzualizare
-
Geriatric Medicines Market Demand Analysis and Future ProspectsRising healthcare expenditure for elderly care is contributing to consistent market growth. Governments and private institutions are investing in aging population management programs. This financial support enhances the adoption of specialized medicines. The geriatric medicines market is witnessing strong and sustained growth as healthcare systems worldwide adapt to the needs of an aging...0 Commentarii 0 Distribuiri 6K Views 0 previzualizare
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Global DXM and Codeine Syrup Market to Reach USD 2.75 Billion by 2034 Amid Rising Respiratory IllnessesAccording to a new report from Intel Market Research, the global DXM and Codeine Syrup market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a CAGR of 7.2% during the forecast period (2026-2034). This growth is driven by increasing respiratory illness prevalence, rising healthcare expenditure in emerging economies, and expanding...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Global Potassium Gluconate Market to Reach USD 520 Million by 2034 Driven by Growing Demand for Electrolyte SupplementsAccording to a new report from Intel Market Research, the global Potassium Gluconate market was valued at USD 320 million in 2025 and is projected to reach USD 520 million by 2034, growing at a steady CAGR of 5.3% during the forecast period (2026–2034). This expansion reflects increasing global demand for electrolyte supplements, food fortification applications, and pharmaceutical...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
Sponsorizeaza Paginile